ITMCTR2000003508尚未招募1 期
Clinical evaluation of Yinchenhao decoction in the treatment of Nonalcoholic Fatty Liver Disease (hepatobiliary dampness-heat syndrome)
Shuguang Hospital affiliated with Shanghai University of TCM0 个研究点开始时间: 待定最近更新:
试验速览
- 阶段
- 1 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional study
入排标准
- 年龄范围
- 18 至 60(—)
- 性别
- All
入选标准
- •Referring to the diagnostic criteria of NAFLD in the guidelines for the prevention and treatment of non-alcoholic fatty liver disease (2018 update), the diagnostic criteria of hepatobiliary dampness-heat syndrome established by the consensus opinion on the diagnosis and treatment of non-alcoholic fatty liver disease by integrated traditional Chinese and western medicine (2017) are as follows:
- •1. Between the ages of 18 years and 60 years (including), there is no limit on sex;
- •2. Patients who meet the diagnostic criteria of NAFLD,Liver imaging findings meet the diagnostic criteria of diffused fatty liver, and there is no other reason to explain and / or have metabolic syndrome related components in patients with unknown causes of serum ALT, / or AST, GGT continued to increase for more than half a year.
- •3. Meet the diagnostic criteria of liver and gallbladder dampness-heat syndrome of traditional Chinese medicine.
- •4. MRI PDFF mean >= 8%, Willing to accept regular physical and chemical examinations related to fatty liver;
- •5. I or my guardian agree to participate in the clinical trial control study and sign the informed consent form.
排除标准
- •1. Alanine aminotransferase (ALT)/aspartate aminotransferase (AST) > 5*ULN, total bilirubin (TBIL) > 2*ULN;
- •2. Alcoholic fatty liver (male alcohol intake > 210g/week, female alcohol intake > 140g/week);
- •3. Combined with viral, autoimmune and other liver diseases, or taking drugs that may cause fatty liver;
- •4. Combined with diabetes (glycated hemoglobin >= 6.5%, or fasting blood glucose >= 7.0mol/L, or 2 hours postprandial blood glucose >= 11.1mmol/L), malignant tumors, connective tissue diseases and severe heart, liver, hematopoietic, and nervous system complications , Or clearly have other important diseases;
- •5. Pregnant or breastfeeding women, allergic physique, allergic to drugs, and patients with mental illness;
- •6. Patients who have undergone gastrointestinal bariatric surgery within the past year or who have taken weight-loss drugs within the past three months have lost >10%.
研究者
相似试验
招募中
1 期
Clinical study on Yixiao Decoction in the treatment of type 2 diabetes complicated with left ventricular diastolic dysfunctioType 2 DiabetesITMCTR2100004708Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine
尚未招募
3 期
Clinical Study of ''Jieyu Xingyang decoction'' in treating erectile dysfunction caused by antipsychoticErectile dysfunction due to antipsychoticsITMCTR2200005913Affiliated Brain Hospital of Guangzhou Medical University
尚未招募
不适用
Clinical study for 'Yi-Qin-Fang' decoction in the treatment of uric acid nephropathy by high colon pathwayric acid nephropathyITMCTR1900002859Shenzhen Second People's Hospital
招募中
1 期
Clinical study of jiuwei Yongan Decoction in treating atopic dermatitis (blood deficiency, wind dryness syndrome)Atopic dermatitisITMCTR2000004007Shanghai Changhai Hospital
尚未招募
1 期
Clinical Evaluation of ZiyinChushi Decoction in the Treatment of Atopic Dermatitis with Yin Deficiency and Dampness Accumulation SyndromeAtopic DermatitisITMCTR2022000042Guang'anmen Hospital, China Academy of Chinese Medical Sciences
